Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism

Pfeifer, 2015, Brown, beige, and white: the new color code of fat and its pharmacological implications, Annual Review of Pharmacology and Toxicology, 55, 207, 10.1146/annurev-pharmtox-010814-124346 Rosen, 2014, What we talk about when we talk about fat, Cell, 156, 20, 10.1016/j.cell.2013.12.012 Cannon, 2004, Brown adipose tissue: function and physiological significance, Physiological Reviews, 84, 277, 10.1152/physrev.00015.2003 Enerback, 2010, Human brown adipose tissue, Cell Metabolism, 11, 248, 10.1016/j.cmet.2010.03.008 Kajimura, 2010, Transcriptional control of brown fat development, Cell Metabolism, 11, 257, 10.1016/j.cmet.2010.03.005 Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, The New England Journal of Medicine, 360, 1509, 10.1056/NEJMoa0810780 Saito, 2009, High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity, Diabetes, 58, 1526, 10.2337/db09-0530 Virtanen, 2009, Functional brown adipose tissue in healthy adults, The New England Journal of Medicine, 360, 1518, 10.1056/NEJMoa0808949 van Marken Lichtenbelt, 2009, Cold-activated brown adipose tissue in healthy men, The New England Journal of Medicine, 360, 1500, 10.1056/NEJMoa0808718 Bartelt, 2011, Brown adipose tissue activity controls triglyceride clearance, Nature Medicine, 17, 200, 10.1038/nm.2297 Nedergaard, 2014, The browning of white adipose tissue: some burning issues, Cell Metabolism, 20, 396, 10.1016/j.cmet.2014.07.005 Mitschke, 2013, Increased cGMP promotes healthy expansion and browning of white adipose tissue, FASEB Journal, 27, 1621, 10.1096/fj.12-221580 Hoffmann, 2015, Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue, Nature Communications, 6, 7235, 10.1038/ncomms8235 de Bold, 1981, A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats, Life Sciences, 28, 89, 10.1016/0024-3205(81)90370-2 Kuhn, 2004, Molecular physiology of natriuretic peptide signalling, Basic Research in Cardiology, 99, 76, 10.1007/s00395-004-0460-0 Potter, 2006, Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions, Endocrine Reviews, 27, 47, 10.1210/er.2005-0014 Boerrigter, 2009, Natriuretic peptides in the diagnosis and management of chronic heart failure, Heart Failure Clinics, 5, 501, 10.1016/j.hfc.2009.04.002 Song, 1988, Brain natriuretic factor. Augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding, FEBS Letters, 232, 125, 10.1016/0014-5793(88)80400-9 Winquist, 1984, Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle, Proceedings of the National Academy of Sciences of the United States of America, 81, 7661, 10.1073/pnas.81.23.7661 Maack, 1992, Receptors of atrial natriuretic factor, Annual Review of Physiology, 54, 11, 10.1146/annurev.ph.54.030192.000303 Suga, 1992, Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide, Endocrinology, 130, 229, 10.1210/endo.130.1.1309330 Kenny, 1993, Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11, Biochemical Journal, 291, 83, 10.1042/bj2910083 Ryden, 2016, Impaired atrial natriuretic peptide-mediated lipolysis in obesity, International Journal of Obesity (London), 40, 714, 10.1038/ijo.2015.222 Plante, 2014, Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice, Diabetologia, 57, 1257, 10.1007/s00125-014-3201-4 Coue, 2015, Defective natriuretic peptide receptor signaling in skeletal muscle links obesity to type 2 diabetes, Diabetes, 64, 4033, 10.2337/db15-0305 Sengenes, 2000, Natriuretic peptides: a new lipolytic pathway in human adipocytes, FASEB Journal, 14, 1345, 10.1096/fasebj.14.10.1345 Bordicchia, 2012, Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes, Journal of Clinical Investigation, 122, 1022, 10.1172/JCI59701 Wang, 2004, Impact of obesity on plasma natriuretic peptide levels, Circulation, 109, 594, 10.1161/01.CIR.0000112582.16683.EA Sengenes, 2002, Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity, American Journal of Physiology Regulatory, Integrative and Comparative Physiology, 283, R257, 10.1152/ajpregu.00453.2001 Cannone, 2011, A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community, Journal of the American College of Cardiology, 58, 629, 10.1016/j.jacc.2011.05.011 Cannone, 2013, Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study, Hypertension, 62, 860, 10.1161/HYPERTENSIONAHA.113.01344 Cannone, 2013, The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population, Diabetes Care, 36, 2850, 10.2337/dc12-2337 Lee, 2016, Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions, European Heart Journal – Cardiovascular Pharmacotherapy, 2, 98, 10.1093/ehjcvp/pvv040 Lee, 2009, Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects, Journal of Clinical Pharmacology, 49, 668, 10.1177/0091270009336233 Inuzuka, 2010, C-type natriuretic peptide as a new regulator of food intake and energy expenditure, Endocrinology, 151, 3633, 10.1210/en.2010-0141 Haas, 2009, Protein kinase g controls brown fat cell differentiation and mitochondrial biogenesis, Science Signalling, 2, ra78 Gnad, 2014, Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors, Nature, 516, 395, 10.1038/nature13816 Nakao, 2015, The local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth, Science Report, 5, 10554, 10.1038/srep10554 Kosteli, 2010, Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue, Journal of Clinical Investigation, 120, 3466, 10.1172/JCI42845 Leto, 2012, Regulation of glucose transport by insulin: traffic control of GLUT4, Nature Reviews. Molecular Cell Biology, 13, 383, 10.1038/nrm3351 Samuel, 2016, The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux, Journal of Clinical Investigation, 126, 12, 10.1172/JCI77812 Lumeng, 2007, Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins, American Journal of Physiology, Endocrinology and Metabolism, 292, E166, 10.1152/ajpendo.00284.2006 Scherer, 2016, The multifaceted roles of adipose tissue-therapeutic targets for diabetes and beyond: the 2015 Banting lecture, Diabetes, 65, 1452, 10.2337/db16-0339 Barnea, 2010, High-fat diet followed by fasting disrupts circadian expression of adiponectin signaling pathway in muscle and adipose tissue, Obesity (Silver Spring), 18, 230, 10.1038/oby.2009.276 Moro, 2013, Natriuretic peptides and cGMP signaling control of energy homeostasis, American Journal of Physiology. Heart Circulatory Physiology, 304, H358, 10.1152/ajpheart.00704.2012 Pfeifer, 2013, Regulation of metabolism by cGMP, Pharmacology & Therapeutics, 140, 81, 10.1016/j.pharmthera.2013.06.001 Schlueter, 2014, Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome, Pharmacology & Therapeutics, 144, 12, 10.1016/j.pharmthera.2014.04.007 Collins, 2014, heart-adipose tissue connection in the regulation of energy metabolism, Nature Reviews. Endocrinology, 10, 157, 10.1038/nrendo.2013.234 Koesling, 1999, Soluble guanylyl cyclase: structure and regulation, Reviews of Physiology, Biochemistry and Pharmacology, 135, 41, 10.1007/BFb0033669 Pfeifer, 1999, Structure and function of cGMP-dependent protein kinases, Reviews of Physiology, Biochemistry and Pharmacology, 135, 105, 10.1007/BFb0033671 Miyashita, 2009, Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity, Diabetes, 58, 2880, 10.2337/db09-0393 Ayala, 2007, Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice, Diabetes, 56, 1025, 10.2337/db06-0883 Lisy, 2008, Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP, Journal of the American College of Cardiology, 52, 60, 10.1016/j.jacc.2008.02.077 Dickey, 2011, Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation, Journal of Molecular and Cellular Cardiology, 51, 67, 10.1016/j.yjmcc.2011.03.013 Martin, 2012, CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart, PLoS One, 7, e52422, 10.1371/journal.pone.0052422 Li, 2012, Knockdown of natriuretic peptide receptor-A enhances receptor C expression and signalling in vascular smooth muscle cells, Cardiovascular Research, 93, 350, 10.1093/cvr/cvr319 Lewko, 2015, Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes, Molecular and Cellular Biochemistry, 409, 243, 10.1007/s11010-015-2528-6 Raha, 2006, Atrial natriuretic peptide enhances cortisol secretion from guinea-pig adrenal gland: evidence for an indirect paracrine mechanism probably involving the local release of medullary catecholamines, International Journal of Molecular Medicine, 17, 633 Kovacova, 2016, Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes, Obesity (Silver Spring), 24, 820, 10.1002/oby.21418 Arejian, 2009, Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK, American Journal of Physiology. Heart Circulatory Physiology, 296, H1859, 10.1152/ajpheart.01108.2008 Yanaka, 1997, Protein kinase C activation down-regulates natriuretic peptide receptor C expression via transcriptional and post-translational pathways, FEBS Letters, 418, 333, 10.1016/S0014-5793(97)01406-3 Dessi-Fulgheri, 1997, Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients, Journal of Hypertension, 15, 1695, 10.1097/00004872-199715120-00074 Pivovarova, 2012, Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?, Journal of Clinical Endocrinology and Metabolism, 97, E731, 10.1210/jc.2011-2839 Sarzani, 2004, Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity, Obesity Research, 12, 351, 10.1038/oby.2004.44 Azer, 2012, Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptors, Journal of Molecular and Cellular Cardiology, 53, 715, 10.1016/j.yjmcc.2012.08.020 Sciarretta, 2013, C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling, Circulation Research, 112, 1355, 10.1161/CIRCRESAHA.113.301325 Rose, 2008, Natriuretic peptide C receptor signalling in the heart and vasculature, Journal of Physiology, 586, 353, 10.1113/jphysiol.2007.144253 Birkenfeld, 2012, Atrial natriuretic peptide and adiponectin interactions in man, PLoS One, 7, e43238, 10.1371/journal.pone.0043238 Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochemical and Biophysical Research Communications, 257, 79, 10.1006/bbrc.1999.0255 Ouchi, 2011, Adipokines in inflammation and metabolic disease, Nature Reviews Immunology, 11, 85, 10.1038/nri2921 Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, Journal of Clinical Investigation, 117, 2621, 10.1172/JCI31021 Odegaard, 2015, Type 2 responses at the interface between immunity and fat metabolism, Current Opinion in Immunology, 36, 67, 10.1016/j.coi.2015.07.003 Kiemer, 1997, Effects of different natriuretic peptides on nitric oxide synthesis in macrophages, Endocrinology, 138, 4282, 10.1210/endo.138.10.5459 Kiemer, 2001, The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages, Annals of the Rheumatic Diseases, 60, iii68 Shaw, 2009, Cyclic GMP protects human macrophages against peroxynitrite-induced apoptosis, Journal of Inflammation (London), 6, 14, 10.1186/1476-9255-6-14 Kammoun, 2014, Adipose tissue inflammation in glucose metabolism, Reviews in Endocrine and Metabolic Disorders, 15, 31, 10.1007/s11154-013-9274-4 Yamada-Goto, 2013, Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice, Diabetes, 62, 1500, 10.2337/db12-0718 Yamashita, 2016, Brain-specific natriuretic peptide receptor-B deletion attenuates high-fat diet-induced visceral and hepatic lipid deposition in mice, Peptides, 81, 38, 10.1016/j.peptides.2016.03.014 McKie, 2016, Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure, European Journal of Heart Failure, 18, 433, 10.1002/ejhf.468 Wan, 2016, Chronic peptide therapy with B-type natriuretic peptide in patients with pre-clinical diastolic dysfunction (stage B heart failure), JACC. Heart Failure, 4, 539, 10.1016/j.jchf.2015.12.014 Chen, 2012, Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide, Journal of the American College of Cardiology, 60, 2305, 10.1016/j.jacc.2012.07.056